In AD patients, along with senile plaques (β-amyloid peptides) and neurofibrillary tangles (tau/phosphorylated tau proteins), inflammatory processes, oxidative stress, mitochondrial dysfunction, and the appearance of reactive gliosis (Ransohoff, 2016) are also evident. This evidence concerns the gene MAPT and Alzheimer disease.